BR112013016789A2 - tratamento da dor associado ao deslocamento do endométrio basal - Google Patents

tratamento da dor associado ao deslocamento do endométrio basal

Info

Publication number
BR112013016789A2
BR112013016789A2 BR112013016789A BR112013016789A BR112013016789A2 BR 112013016789 A2 BR112013016789 A2 BR 112013016789A2 BR 112013016789 A BR112013016789 A BR 112013016789A BR 112013016789 A BR112013016789 A BR 112013016789A BR 112013016789 A2 BR112013016789 A2 BR 112013016789A2
Authority
BR
Brazil
Prior art keywords
displacement
pain associated
treatment
basal endometrium
endometrium
Prior art date
Application number
BR112013016789A
Other languages
English (en)
Inventor
Elke Bestel
Ernest Loumaye
Lan Osterloh
Original Assignee
Preglem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Preglem Sa filed Critical Preglem Sa
Publication of BR112013016789A2 publication Critical patent/BR112013016789A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

tratamento da dor associado ao deslocamento do endométrio basal a presente invenção refere-se em geral às doenças ginecológicas e em particular a um método para a redução da dor associada ao deslocamento do endométrio basal.
BR112013016789A 2010-12-30 2011-12-23 tratamento da dor associado ao deslocamento do endométrio basal BR112013016789A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201061457107P 2010-12-30 2010-12-30
EP10197400A EP2471537A1 (en) 2010-12-30 2010-12-30 Treatment of pain associated with dislocation of basal endometrium
PCT/IB2011/055941 WO2012090143A1 (en) 2010-12-30 2011-12-23 Treatment of pain associated with dislocation of basal endometrium

Publications (1)

Publication Number Publication Date
BR112013016789A2 true BR112013016789A2 (pt) 2016-10-11

Family

ID=43928060

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013016789A BR112013016789A2 (pt) 2010-12-30 2011-12-23 tratamento da dor associado ao deslocamento do endométrio basal

Country Status (20)

Country Link
US (1) US10441593B2 (pt)
EP (2) EP2471537A1 (pt)
JP (2) JP5991988B2 (pt)
KR (1) KR101940824B1 (pt)
CN (1) CN103313715A (pt)
AU (1) AU2011350717B2 (pt)
BR (1) BR112013016789A2 (pt)
CA (1) CA2818468C (pt)
CO (1) CO6821932A2 (pt)
EA (1) EA024609B1 (pt)
GE (1) GEP20166449B (pt)
HU (1) HUE048027T2 (pt)
IL (1) IL227080B (pt)
MX (1) MX353302B (pt)
MY (1) MY170934A (pt)
NZ (1) NZ612717A (pt)
SG (1) SG191360A1 (pt)
UA (1) UA112173C2 (pt)
WO (1) WO2012090143A1 (pt)
ZA (1) ZA201304868B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ789295A (en) 2009-04-29 2024-02-23 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
NZ627238A (en) 2009-04-29 2016-02-26 Amarin Pharmaceuticals Ie Ltd Stable pharmaceutical composition comprising ethyl eicosapentaenoate
CN114053258A (zh) * 2009-06-15 2022-02-18 阿马里纳药物爱尔兰有限公司 在相伴他汀类疗法的对象中降低甘油三酯、没有增加ldl-c水平的组合物和方法
NZ778131A (en) 2010-11-29 2023-03-31 Amarin Pharmaceuticals Ie Ltd Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
FR2997627B1 (fr) * 2012-11-08 2015-01-16 Hra Pharma Lab Produit de co-micronisation comprenant de l'ulipristal acetate
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
US20140271841A1 (en) 2013-03-15 2014-09-18 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
US10172818B2 (en) 2014-06-16 2019-01-08 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
CN112218630A (zh) 2018-09-24 2021-01-12 阿马里纳药物爱尔兰有限公司 降低受试者的心血管事件的风险的方法
KR20200131096A (ko) 2019-05-13 2020-11-23 박만금 휴대용 단말기 거치 겸용 휴대용 공기청정기
WO2022225896A1 (en) 2021-04-21 2022-10-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of heart failure

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4954490A (en) 1988-06-23 1990-09-04 Research Triangle Institute 11 β-substituted progesterone analogs
US5929262A (en) 1995-03-30 1999-07-27 The United States Of America As Represented By The Department Of Health And Human Services Method for preparing 17α-acetoxy-11β-(4-N, N-dimethylaminophyl)-19-Norpregna-4,9-diene-3, 20-dione, intermediates useful in the method, and methods for the preparation of such intermediates
US6900193B1 (en) * 1996-05-01 2005-05-31 The United States Of America As Represented By The Department Of Health And Human Services Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents
ES2212912B1 (es) 2003-01-22 2005-10-01 Crystal Pharma, S.A. Procedimiento para la obtencion de 17alfa-acetoxi-11beta-(4-n,n-dimetilaminofenil)-19-norpregna-4,9-dien-3,20-diona.
JP2006519255A (ja) 2003-02-28 2006-08-24 アメリカ合衆国 １７α−アセトキシ−１１β−（４−Ｎ，Ｎ−ジメチルアミノフェニル）−１９−ノルプレグナ−４，９−ジエン−３，２０−ジオンの製造方法、その中間体及びそのような中間体の製造方法
HUE025239T2 (en) * 2003-09-03 2016-03-29 Miscon Trading S A Methods for treating endometriosis
WO2007103510A2 (en) * 2006-03-08 2007-09-13 Danco Laboratories Llc Methods, dosing regimens & medications using anti-progestational agents for the treatment of disorders
SI3263112T1 (sl) 2006-10-24 2020-10-30 Allergan Pharmaceuticals International Limited Sestavki in metode za zaviranje endometrijskih proliferacij
TW200831110A (en) * 2006-12-28 2008-08-01 Repros Therapeutics Inc Methods and formulations for improved bioavailability of antiprogestins
PT2148681E (pt) * 2007-04-20 2016-06-17 Preglem Sa Moduladores seletivos da progesterona no tratamento da hemorragia uterina
US8299050B2 (en) * 2008-01-29 2012-10-30 Laboratoire Hra-Pharma Method for treating uterine fibroids
TWI477276B (zh) * 2008-04-28 2015-03-21 Repros Therapeutics Inc 抗黃體素給藥方案
FR2937862B1 (fr) 2008-11-03 2010-11-19 Mohammed Ridha Chakroun Kit contraceptif
US8512745B2 (en) * 2008-12-08 2013-08-20 Laboratoire Hra Pharma Ulipristal acetate tablets
US8426392B2 (en) * 2009-12-09 2013-04-23 Laboratoire Hra-Pharma Method for providing emergency contraception

Also Published As

Publication number Publication date
IL227080B (en) 2018-01-31
EP2658545B1 (en) 2019-10-23
SG191360A1 (en) 2013-08-30
ZA201304868B (en) 2014-03-26
EA201390948A1 (ru) 2013-11-29
JP2014501272A (ja) 2014-01-20
MY170934A (en) 2019-09-19
US10441593B2 (en) 2019-10-15
US20130281422A1 (en) 2013-10-24
CA2818468C (en) 2019-11-19
CN103313715A (zh) 2013-09-18
NZ612717A (en) 2015-07-31
MX353302B (es) 2018-01-08
HUE048027T2 (hu) 2020-05-28
JP5991988B2 (ja) 2016-09-14
AU2011350717B2 (en) 2016-11-24
MX2013007690A (es) 2013-12-06
UA112173C2 (uk) 2016-08-10
GEP20166449B (en) 2016-03-25
KR101940824B1 (ko) 2019-01-21
WO2012090143A1 (en) 2012-07-05
EP2658545A1 (en) 2013-11-06
EP2471537A1 (en) 2012-07-04
JP2016175943A (ja) 2016-10-06
KR20140017511A (ko) 2014-02-11
AU2011350717A1 (en) 2013-06-27
EA024609B1 (ru) 2016-10-31
CA2818468A1 (en) 2012-07-05
CO6821932A2 (es) 2013-12-31

Similar Documents

Publication Publication Date Title
BR112013016789A2 (pt) tratamento da dor associado ao deslocamento do endométrio basal
PL2704704T3 (pl) Bakterie probiotyczne do miejscowego leczenia zaburzeń skóry
EP2897625A4 (en) AMNIOTIC MEMBRANE AND USE THEREOF IN WOUND HEALING CONSTRUCTION AND TISSUE ENGINEERING CONSTRUCTS
MX2015008114A (es) Derivados de exendina-4.
BR112012027707A2 (pt) dispositivo médico para tratar tecido rígido
BR112013011730A2 (pt) composição de oligossacarídeos para tratar doenças da pele
AU2012205878A8 (en) miRNA for treating diseases and conditions associated with neo-angiogenesis
IL229474A0 (en) Cannabinoids for use in the treatment of neuropathic pain
AU339607S (en) Medical device for treatment of sleep disorders
BRDI7106622S (pt) Configuração aplicada em remédio para alívio de dor
BR112013031790A8 (pt) indicador de pressão, uso do mesmo, dispositivo médico e dispositivo médico para anestesia epidural
ZA201308459B (en) A topical formulation for treatment of hyperkeratotic skin
BRPI1011912A2 (pt) l-serina para uso como medicamento para prevenir e/ou tratar uma reação inflamatória da pele.
PT2810599T (pt) Sistema de estimulação elétrica para o tratamento da apneia do sono
MX357656B (es) Alfa-1-microglobulina para usarse en tratamiento de enfermedades relacionadas a mitocondrias.
HK1255668A1 (zh) 用於治療皮膚病症的包含二吲哚基甲烷和類視黃醇的組合物
BR112013004721A2 (pt) "quinolina-3-carboxamidas substituídas como moduladores de kcnq2/3"
ZA201502288B (en) Ciclesonide for treatment of airway disease in horses
HK1207593A1 (en) Medicament for treating mental and behavioural disorders
EP2709632A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF SKIN DISEASES
BR112013020359B8 (pt) Colágeno gelificável e meios para a sua provisão
BR112014017587A8 (pt) métodos e formulações para o tratamento de deficiências de ácido siálico
BR112012024704A8 (pt) uso terapêutico de tetratiomolibdato.
MY158112A (en) Use of agomelatine in obtaining medicaments intended for the treatment of obsessive-compulsive disorder (ocd)
WO2012004416A3 (en) Treatment of a disease associated with retinal degenerative disorder

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL

B350 Update of information on the portal [chapter 15.35 patent gazette]